Clinical Trial Update: Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety, efficacy, and dose response of GSK573719 in combination with Fluticasone Furoate in subjects with asthma; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• GSK573719

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-15